Login
$RXST
$4.93 -$0.09 (1.79%) Close

$RXST 8-K/A SEC Filings

Filed On Filing
19 Mar 2026 8-K/A: Departure/Election of Directors or Officers; Compensation

On January 12, 2026, RxSight, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Initial Report”) with the Securities and Exchange Commission to report, among other things, the appointment of Mark Wilterding as the Company’s C...

15 Aug 2025 8-K/A: Departure/Election of Directors or Officers; Compensation

This Amendment No. 1 to Current Report on Form 8-K/A (the “Amendment”) amends the Current Report on Form 8-K of RxSight, Inc. (the “Company”) dated July 31, 2025 and filed with the Securities and Exchange Commission on August 4, 2025 (th...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support